Table 15. IgM ELISA cut-off point results against population parameters, univariate analysis including stratification by sex.
|
Sex (Row%) (Col%) |
Weight* (95% CI) UGV-1: N = 69; UHV- NP, UHV-1 NP-C: N = 70 |
Age**(n) (95% CI) UGV-1: N = 66; UHV-1 NP, UHV-1 NP-C: N = 67 |
|||||||
| M | F | Total | M | F | Total | M | F | Total | |
|
UGV- 1 IgM ELISA -ve |
14 (41.18%) (41.18%) |
20 (58.82%) (57.14%) |
34 (100.00%) (49.28%) |
2.623 (2.204–3.120) |
3.771 (2.867–4.962) |
3.248 (2.712–3.889) |
5.000 (13) (3.983–6.017) |
4.750 (20) (4.145–5.355) |
4.848 (33) (4.338–5.359) |
|
UGV-1 IgM ELISA +ve |
20 (57.14%) (58.82%) |
15 (42.86%) (42.86%) |
35 (100.00%) (50.72%) |
1.724 (1.424–2.087) |
3.949 (3.089–5.048) |
2.459 (2.008–3.011) |
3.889 (18) (3.167–4.610) |
4.867 (15) (4.060–5.674) |
4.333 (33) 3.797–4.870) |
| Total |
34 (49.28%) 100.00%) |
35 (50.72%) (100.00%) |
69 (100.00%) (100.00%) |
2.049 (1.770–2.372) |
3.938 (3.287–4.719) |
2.820 (2.461–3.233) |
4.355 (31) (3.759–4.950) |
4.800 (35) (4.338–5.262) |
4.595 (66) (4.225–5.957) |
| χ2 = 1.7590, p = 0.185 | t = 3.2678, df = 32 p<0.01 |
t = -0.2540, df = 33 p = 0.818 |
t = 2.0827, df = 67 p<0.05 |
t = 1.968, df = 29 p = 0.0578 |
t = -0.2502, df = 33 p = 0.8040 |
t = 1.417, df = 67 p = 0.161 |
|||
|
UHV-1 NP IgM ELISA -ve |
27 (50.00%) (79.41%) |
27 (50.00%) (75.00%) |
54 (100.00%) (77.14%) |
2.042 (1.757–2.374) |
3.841 (3.109–4.746) |
2.801 (2.404–3.263) |
4.280 (25) (3.633–4.927) |
4.778 (27) (4.237–5.319) |
4.538 (52) (4.128–4.949) |
|
UHV-1 NP IgM ELISA +ve |
7 (43.75%) (20.59%) |
9 (56.25%) (25.00%) |
16 (100.00%) (22.86%) |
2.075 (1.212–3.553) |
4.245 (2.764–6.521) |
3.104 (2.183–4.413) |
4.667 (6) (2.603–6.730) |
5.111 (9) (3.994–6.228) |
4.629 (15) (4.034 (4.260–4.994) |
| χ2 = 0.1930, p = 0.660 | t = -0.0881, df = 32 p = 0.9304 |
t = -0.4807, df = 34 p = 0.6338 |
t = -0.6185, df = 68 p = 0.538 |
t = -0.5174, df = 29 p = 0.6088 |
t = -0.6237, df = 34 p = 0.5370 |
t = -0.893, df = 65 p = 0.375 |
|||
|
UHV-1 NP-C IgM ELISA -ve |
21 (48.84%) (61.76%) |
22 (51.16%) (61.11%) |
43 (100.00%) (61.43%) |
2.155 (1.812–2.564) |
3.754 (3.003–4.602) |
2.863 (2.436–3.364) |
4.350 (20) (3.617–5.083) |
4.682 (22) (4.200–5.163) |
4.524 (42) (4.109–4.938) |
|
UHV-1 NP-C IgM ELISA +ve |
13 (48.15%) (38.24%) |
14 (51.85%) (38.89%) |
27 (100.00%) (38.57%) |
1.888 (1.414–2.521) |
4.247 (3.018–5.978) |
2.875 (2.204–3.750) |
4.364 (11) (3.152–5.576) |
5.143 (14) (4.134–6.152) |
4.800 (25) (4.065–4.994) |
| χ2 = 0.0032, p = 0.955 | t = 0.8911, df = 32 p = 0.3795 |
t = -0.6709, df = 34 p = 0.5068 |
t = -0.295, df = 68 p = 0.797 |
t = -0.022, df = 29 p = 0.9826 |
t = -0.9792, df = 34 p = 0.3344 |
t = -0.723, df = 65 p = 0.472 |
|||
| Total |
34 (48.57%) (100.00%) |
36 (51.43%) (100.00%) |
70 (100.00%) (100.00%) |
2.049 (1.770–2.372) |
3.938 (3.287–4.719) |
2.867 (2.497–3.293) |
4.355 (31) (3.759–4.950) |
4.861 (36) (4.395–5.327) |
4.626 (67) (4.260–4.994) |
*Kg, geometric mean
**Mean Years